[1] Gurtner GC, Werner S, Barrandon Y, et al. Wound repair and regeneration. Nature. 2008;453(7193):314-321. [2] Ho S, Marçal H, Foster LJ. Towards scarless wound healing: a comparison of protein expression between human, adult and foetal fibroblasts. Biomed Res Int. 2014;2014:676493.[3] Rodriguez AM, Elabd C, Amri EZ, et al. The human adipose tissue is a source of multipotent stem cells. Biochimie. 2005; 87(1):125-128.[4] Jung H, Kim HH, Lee DH, et al. Transforming growth factor-beta 1 in adipose derived stem cells conditioned medium is a dominant paracrine mediator determines hyaluronic acid and collagen expression profile. Cytotechnology. 2011;63(1):57-66.[5] Kim WS, Park BS, Sung JH, et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci. 2007;48(1): 15-24.[6] Thielitz A, Vetter RW, Schultze B, et al. Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts. J Invest Dermatol. 2008; 128(4):855-866.[7] Xing L, Franz MG, Marcelo CL, et al. Amnion-derived multipotent progenitor cells increase gain of incisional breaking strength and decrease incidence and severity of acute wound failure. J Burns Wounds. 2007;7:e5.[8] Jung KH, Song SU, Yi T, et al. Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology. 2011; 140(3):998-1008.[9] Rodbell M. Metabolism of isolated fat cells. II. The similar effects of phospholipase C (Clostridium perfringens alpha toxin) and of insulin on glucose and amino acid metabolism. J Biol Chem. 1966;241(1):130-139.[10] Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211-228.[11] Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12): 4279-4295.[12] Chlupác J, Filová E, Bacáková L. Vascular prostheses: 50 years of advancement from synthetic towards tissue engineering and cell therapy. Rozhl Chir. 2010;89(1):85-94.[13] Ramos TV, Wang T, Maki CB, et al. Adipose stem cell side population in the mouse. J Tissue Eng Regen Med. 2009; 3(6):430-441.[14] Diekman BO, Estes BT, Guilak F. The effects of BMP6 overexpression on adipose stem cell chondrogenesis: Interactions with dexamethasone and exogenous growth factors. J Biomed Mater Res A. 2010;93(3):994-1003.[15] Fraser JK, Wulur I, Alfonso Z, et al. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol. 2006;24(4):150-154.[16] Secretan C, Bagnall KM, Jomha NM. Effects of introducing cultured human chondrocytes into a human articular cartilage explant model. Cell Tissue Res. 2010;339(2):421-427.[17] Ahmed N, Taylor DW, Wunder J, et al. Passaged human chondrocytes accumulate extracellular matrix when induced by bovine chondrocytes. J Tissue Eng Regen Med. 2010; 4(3):233-241.[18] Werdin F, Tenenhaus M, Rennekampff HO. Chronic wound care. Lancet. 2008;372(9653):1860-1862.[19] Goldberg SR, Diegelmann RF. Wound healing primer. Surg Clin North Am. 2010;90(6):1133-1146.[20] Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366(9498):1736-1743.[21] Jo DI, Yang HJ, Kim SH, et al. Coverage of skin defects without skin grafts using adipose-derived stem cells. Aesthetic Plast Surg. 2013;37(5):1041-1051.[22] Marino G, Moraci M, Armenia E, et al. Therapy with autologous adipose-derived regenerative cells for the care of chronic ulcer of lower limbs in patients with peripheral arterial disease. J Surg Res. 2013;185(1):36-44.[23] Yun IS, Jeon YR, Lee WJ, et al. Effect of human adipose derived stem cells on scar formation and remodeling in a pig model: a pilot study. Dermatol Surg. 2012;38(10):1678-1688.[24] Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107(1):367-372.[25] Yun IS, Jeon YR, Lee WJ, et al. Effect of human adipose derived stem cells on scar formation and remodeling in a pig model: a pilot study. Dermatol Surg. 2012;38(10):1678-1688.[26] Welsh J. Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys. 2012;523(1): 107-114.[27] Zhou YS, Liu YS, Tan JG. Is 1, 25-dihydroxyvitamin D3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue-derived stromal cells in vitro. Chin Med J (Engl). 2006;119(15):1278-1286.[28] Fromigué O, Marie PJ, Lomri A. Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine. 1997;9(8):613-623.[29] Curtis KM, Aenlle KK, Frisch RN, et al. TAp63γ and ΔNp63β promote osteoblastic differentiation of human mesenchymal stem cells: regulation by vitamin D3 Metabolites. PLoS One. 2015;10(4):e0123642.[30] 沈小辉,杨华清,唐文娟,等. 1α,25-二羟维生素D3对成骨细胞增殖分化、Ⅰ型胶原及核心结合因子α-1基因表达的影响[J]. 实用老年医学,2014,28(6):500-505.[31] 吴学建,程省,陶金刚. 1,25(OH)2VD3对人脐带间充质干细胞增殖及成骨分化的影响[J]. 中华显微外科杂志, 2011, 34(5): 386-389.[32] 柳逸博,王佐林. 浓缩生长因子与1,25二羟基维生素D3对骨髓间充质干细胞增殖与成骨分化的影响[J]. 口腔颌面外科杂志, 2016,26(1):13-18.[33] Potter JJ, Liu X, Koteish A, et al. 1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1 (I) collagen expression and type I collagen formation. Liver Int. 2013; 33(5):677-686.[34] Bläuer M, Sand J, Laukkarinen J. Physiological and clinically attainable concentrations of 1,25-dihydroxyvitamin D3 suppress proliferation and extracellular matrix protein expression in mouse pancreatic stellate cells. Pancreatology. 2015;15(4):366-371.[35] Ramirez AM, Wongtrakool C, Welch T, et al. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol. 2010;118(3):142-150. [36] Halder SK, Osteen KG, Al-Hendy A. 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol Reprod. 2013;89(6):150.[37] Sato M. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. Acta Derm Venereol. 2006;86(4):300-307.[38] Li Y, Zou N, Wang J, et al. TGF-β1/Smad3 Signaling Pathway Mediates T-2 Toxin-Induced Decrease of Type II Collagen in Cultured Rat Chondrocytes. Toxins (Basel). 2017;9(11): E359. |